Loading data
DNTHNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.04 m USD | 6.24 m USD | 2.83 m USD | — | — |
| Research and development expense | 145.64 m USD | 83.11 m USD | 32.84 m USD | 29.38 m USD | 12.61 m USD |
| Operating profit | -177.93 m USD | -101.86 m USD | -48.17 m USD | -29.71 m USD | -13.09 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -162.34 m USD | -84.97 m USD | -43.56 m USD | -28.48 m USD | -13.11 m USD |
| Basic earnings per share | -4.2 USD/share | -2.55 USD/share | -8.45 USD/share | -32.57 USD/share | -15.01 USD/share |
| Diluted earnings per share | -4.2 USD/share | -2.55 USD/share | -8.45 USD/share | -32.57 USD/share | -15.01 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.